ArticleBMJ neurology open2024

Twelve-month efficacy of CGRP monoclonal antibodies and predictive value of short-term response: results of an Australian multicentre study.

Jason Charles Ray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.